Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sefrin JP"'
Autor:
Richards DM; Research and Development, Apogenix AG, Heidelberg, Germany., Sefrin JP; Research and Development, Apogenix AG, Heidelberg, Germany., Gieffers C; Research and Development, Apogenix AG, Heidelberg, Germany., Hill O; Research and Development, Apogenix AG, Heidelberg, Germany., Merz C; Research and Development, Apogenix AG, Heidelberg, Germany.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2020; Vol. 16 (2), pp. 377-387. Date of Electronic Publication: 2019 Sep 05.
Autor:
Sefrin JP; Discovery Oncology, Roche Innovation Center Penzberg, Roche Pharma Research and Early Development, Penzberg, Germany., Hillringhaus L; Department of Early Development and Reagent Design, Roche Diagnostics GmbH, Penzberg, Germany., Mundigl O; Large Molecule Research, Roche Innovation Center Penzberg, Roche Pharma Research and Early Development, Penzberg, Germany., Mann K; Discovery Oncology, Roche Innovation Center Penzberg, Roche Pharma Research and Early Development, Penzberg, Germany., Ziegler-Landesberger D; Large Molecule Research, Roche Innovation Center Penzberg, Roche Pharma Research and Early Development, Penzberg, Germany., Seul H; Large Molecule Research, Roche Innovation Center Penzberg, Roche Pharma Research and Early Development, Penzberg, Germany., Tabares G; Department of Early Development and Reagent Design, Roche Diagnostics GmbH, Penzberg, Germany., Knoblauch D; Department of Early Development and Reagent Design, Roche Diagnostics GmbH, Penzberg, Germany., Leinenbach A; Department of Early Development and Reagent Design, Roche Diagnostics GmbH, Penzberg, Germany., Friligou I; Department of Early Development and Reagent Design, Roche Diagnostics GmbH, Penzberg, Germany., Dziadek S; Translational Medicine Oncology, Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland., Offringa R; Department of General Surgery, Heidelberg University Hospital, Heidelberg, Germany.; Division of Molecular Oncology of Gastrointestinal Tumors, German Cancer Research Center, Heidelberg, Germany., Lifke V; Personalized Healthcare Solution, Immunoassay Development and System Integration, Roche Diagnostics GmbH, Penzberg, Germany., Lifke A; Pharma Biotech Penzberg, Roche Diagnostics GmbH, Penzberg, Germany.
Publikováno v:
Frontiers in immunology [Front Immunol] 2019 Aug 21; Vol. 10, pp. 1962. Date of Electronic Publication: 2019 Aug 21 (Print Publication: 2019).
Autor:
Richards DM; Research and Development, Apogenix AG, Im Neuenheimer Feld 584, 69120, Heidelberg, Germany., Marschall V; Present address: Biotest AG, Dreieich, Germany., Billian-Frey K; Research and Development, Apogenix AG, Im Neuenheimer Feld 584, 69120, Heidelberg, Germany., Heinonen K; Research and Development, Apogenix AG, Im Neuenheimer Feld 584, 69120, Heidelberg, Germany., Merz C; Research and Development, Apogenix AG, Im Neuenheimer Feld 584, 69120, Heidelberg, Germany., Redondo Müller M; Research and Development, Apogenix AG, Im Neuenheimer Feld 584, 69120, Heidelberg, Germany., Sefrin JP; Research and Development, Apogenix AG, Im Neuenheimer Feld 584, 69120, Heidelberg, Germany., Schröder M; Research and Development, Apogenix AG, Im Neuenheimer Feld 584, 69120, Heidelberg, Germany., Sykora J; Research and Development, Apogenix AG, Im Neuenheimer Feld 584, 69120, Heidelberg, Germany., Fricke H; Present address: SOTIO, Prague, Czech Republic., Hill O; Research and Development, Apogenix AG, Im Neuenheimer Feld 584, 69120, Heidelberg, Germany., Gieffers C; Research and Development, Apogenix AG, Im Neuenheimer Feld 584, 69120, Heidelberg, Germany., Thiemann M; Research and Development, Apogenix AG, Im Neuenheimer Feld 584, 69120, Heidelberg, Germany. meinolf.thiemann@apogenix.com.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2019 Jul 19; Vol. 7 (1), pp. 191. Date of Electronic Publication: 2019 Jul 19.
Autor:
Thiemann M; Apogenix AG, Heidelberg, Germany., Richards DM; Apogenix AG, Heidelberg, Germany., Heinonen K; Apogenix AG, Heidelberg, Germany., Kluge M; Apogenix AG, Heidelberg, Germany., Marschall V; Apogenix AG, Heidelberg, Germany., Merz C; Apogenix AG, Heidelberg, Germany., Redondo Müller M; Apogenix AG, Heidelberg, Germany., Schnyder T; Apogenix AG, Heidelberg, Germany., Sefrin JP; Apogenix AG, Heidelberg, Germany., Sykora J; Apogenix AG, Heidelberg, Germany., Fricke H; Apogenix AG, Heidelberg, Germany., Gieffers C; Apogenix AG, Heidelberg, Germany., Hill O; Apogenix AG, Heidelberg, Germany.
Publikováno v:
Frontiers in oncology [Front Oncol] 2018 Sep 19; Vol. 8, pp. 387. Date of Electronic Publication: 2018 Sep 19 (Print Publication: 2018).
The Contained Self-Reactive Peripheral T Cell Repertoire: Size, Diversity, and Cellular Composition.
Autor:
Richards DM; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center, 69120 Heidelberg, Germany; and., Ruggiero E; Division of Translational Oncology, German Cancer Research Center and National Center for Tumor Diseases, 69120 Heidelberg, Germany., Hofer AC; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center, 69120 Heidelberg, Germany; and., Sefrin JP; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center, 69120 Heidelberg, Germany; and., Schmidt M; Division of Translational Oncology, German Cancer Research Center and National Center for Tumor Diseases, 69120 Heidelberg, Germany., von Kalle C; Division of Translational Oncology, German Cancer Research Center and National Center for Tumor Diseases, 69120 Heidelberg, Germany., Feuerer M; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center, 69120 Heidelberg, Germany; and m.feuerer@dkfz-heidelberg.de.
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2015 Sep 01; Vol. 195 (5), pp. 2067-79. Date of Electronic Publication: 2015 Jul 20.
Autor:
Teodorczyk M; Molecular Neurobiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Kleber S; Molecular Neurobiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Wollny D; Molecular Neurobiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Sefrin JP; Molecular Neurobiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Aykut B; Molecular Neurobiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Mateos A; Molecular Neurobiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Herhaus P; Molecular Neurobiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Sancho-Martinez I; Molecular Neurobiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hill O; Apogenix GmbH, Heidelberg, Germany., Gieffers C; Apogenix GmbH, Heidelberg, Germany., Sykora J; Apogenix GmbH, Heidelberg, Germany., Weichert W; Institute of Pathology, University of Heidelberg, Heidelberg, Germany., Eisen C; 1] Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany [2] Heidelberg Institute for Stem Cell Technology and Experimental Medicine gGmbH, Heidelberg, Germany., Trumpp A; 1] Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany [2] Heidelberg Institute for Stem Cell Technology and Experimental Medicine gGmbH, Heidelberg, Germany [3] German Cancer Consortium (DKTK), Heidelberg, Germany., Sprick MR; 1] Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany [2] Heidelberg Institute for Stem Cell Technology and Experimental Medicine gGmbH, Heidelberg, Germany., Bergmann F; Institute of Pathology, University of Heidelberg, Heidelberg, Germany., Welsch T; Department of General, Visceral and Transplantation Surgery, Heidelberg, Germany., Martin-Villalba A; Molecular Neurobiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v:
Cell death and differentiation [Cell Death Differ] 2015 Jul; Vol. 22 (7), pp. 1192-202. Date of Electronic Publication: 2015 Jan 23.